Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$497M |
| 2 |
Oracle
ORCL
|
+$404M |
| 3 |
Texas Instruments
TXN
|
+$382M |
| 4 |
Keurig Dr Pepper
KDP
|
+$378M |
| 5 |
Procter & Gamble
PG
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.47B |
| 2 |
Teradyne
TER
|
+$689M |
| 3 |
Applied Materials
AMAT
|
+$515M |
| 4 |
Broadcom
AVGO
|
+$498M |
| 5 |
SNDK
Sandisk
SNDK
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.6% |
| 2 | Industrials | 8.61% |
| 3 | Consumer Discretionary | 8.29% |
| 4 | Healthcare | 7.91% |
| 5 | Financials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Pliant Therapeutics
PLRX
$71.8M
| $22.9K | ﹤0.01% |
20,073
-26,981
| -57% | -$32.8K |
|
|
ATYR
3802
aTyr Pharma
ATYR
$49.2M
| $22.2K | ﹤0.01% |
+37,278
| New | +$24.4K |
|
3803
CALL
Resideo Technologies
REZI
$3.08B
| $21.8K | ﹤0.01% |
700
-7,900
| -92% | -$272K |
|
3804
DocGo
DCGO
$43M
| $21.4K | ﹤0.01% |
+41,421
| New | +$24.8K |
|
3805
Myomo
MYO
$68.5M
| $20.7K | ﹤0.01% |
+19,912
| New | +$19.4K |
|
|
FFAI
3806
Faraday Future Intelligent Electric
FFAI
$12.3M
| $20.6K | ﹤0.01% |
+597
| New | +$29.5K |
|
3807
PUT
DexCom
DXCM
$34.8B
| $20.2K | ﹤0.01% |
300
-24,500
| -99% | -$1.63M |
|
3808
TRX Gold Corp
TRX
$393M
| $20.2K | ﹤0.01% |
23,493
-1,613
| -6% | -$1.87K |
|
3809
eHealth
EHTH
$39.4M
| $20.2K | ﹤0.01% |
+13,531
| New | +$22.7K |
|
|
DDL
3810
Dingdong
DDL
$540M
| $20K | ﹤0.01% |
10,365
-36,859
| -78% | -$91.5K |
|
3811
Blink Charging
BLNK
$86.2M
| $19.9K | ﹤0.01% |
31,039
+6,189
| +25% | +$4.48K |
|
|
CRDL
3812
Cardiol Therapeutics
CRDL
$217M
| $19.5K | ﹤0.01% |
+18,354
| New | +$23.2K |
|
|
PLG
3813
Platinum Group Metals
PLG
$210M
| $19.3K | ﹤0.01% |
+14,298
| New | +$23.9K |
|
3814
SKYX Platforms
SKYX
$156M
| $19.3K | ﹤0.01% |
+17,442
| New | +$19.3K |
|
3815
Siebert Financial
SIEB
$83.4M
| $18.8K | ﹤0.01% |
+11,398
| New | +$20.7K |
|
|
OPENL
3816
Opendoor Technologies Inc Series A Warrants
OPENL
$4.14M
| $18.1K | ﹤0.01% |
64,077
+15,420
| +32% | +$4.73K |
|
3817
CALL
Sony
SONY
$140B
| $18.1K | ﹤0.01% |
900
-38,100
| -98% | -$803K |
|
3818
PUT
Sweetgreen
SG
$832M
| $17.6K | ﹤0.01% |
+2,000
| New | +$15.3K |
|
|
LFT
3819
Lument Finance Trust
LFT
$35M
| $17.5K | ﹤0.01% |
+18,973
| New | +$21.6K |
|
3820
CALL
Wave Life Sciences
WVE
$1.04B
| $16.3K | ﹤0.01% |
2,800
-33,800
| -92% | -$224K |
|
3821
PUT
Qfin Holdings
QFIN
$1.41B
| $15.8K | ﹤0.01% |
+1,000
| New | +$14K |
|
3822
Hain Celestial
HAIN
$71.6M
| $15.7K | ﹤0.01% |
+28,005
| New | +$20.8K |
|
|
OPENZ
3823
Opendoor Technologies Inc Series Z Warrants
OPENZ
$3.99M
| $15.4K | ﹤0.01% |
64,077
+15,420
| +32% | +$4.42K |
|
3824
PUT
Becton Dickinson
BDX
$52.3B
| $15.1K | ﹤0.01% |
100
-12,600
| -99% | -$1.88M |
|
|
FLNA
3825
Filana Therapeutics
FLNA
$46.4M
| $13.8K | ﹤0.01% |
11,575
-27,546
| -70% | -$39.2K |
|
Similar funds
Steven Cohen's Q2 2026 Portfolio in Review
As of Q2 2026, Steven Cohen held 4,738 positions worth $90.7B, up 16% from $78.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steven Cohen withdrew a net $3.54B in Q2 2026, closing 815 positions and reducing 1,446 holdings. Its most notable exit was Parker-Hannifin, an estimated $250M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Texas Instruments worth $410M.
- Steven Cohen's largest Q2 2026 buy was Texas Instruments: 1,377,090 shares worth $410M.
- Steven Cohen added most to Snowflake in Q2 2026, an estimated $497M increase.
- Steven Cohen's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.47B.
- Steven Cohen fully exited Parker-Hannifin in Q2 2026, selling an estimated $250M.
- Steven Cohen's ten largest holdings make up 11% of its $90.7B portfolio in Q2 2026.
- Steven Cohen opened 1,048 new positions and closed 815 in Q2 2026.
- Steven Cohen's portfolio value rose 16% quarter-over-quarter to $90.7B.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.